In a recent study, researchers sought to examine treatment patterns, healthcare utilization, and costs among patients diagnosed with schizophrenia receiving oral therapy vs long-acting injectable...
While patients with schizophrenia are known to have an increased risk of obesity and metabolic disease, knowledge regarding eating behaviors in this patient population is still limited.
Adam Sacarny, PhD, from Columbia University, gives insight on his latest research, which investigated the capacity of peer comparison review letters to help reduce inappropriate and off-label Seroquel...
Using 2013-2015 insurance claims data for more than 17,000 individuals with opioid use disorder, researchers aimed to estimate the rates of buprenorphine treatment retention for at least 180 days and to...
Using National Health Insurance claims data from patients with schizophrenia and type 2 diabetes in Taiwan, researchers sought to investigate the prevalence and characteristics of schizophrenia in this...
In the absence of well-grounded recommendations for the treatment of insomnia in schizophrenia patients, researchers conducted a systematic review of 4 studies that examined the effects of various options...
Dr Shailen Sutaria from Imperial College London in the United Kingdom discusses the clinical implications of his new study, which suggested that children with obesity have an increased risk for depression...
Researchers assessed the risk for type 2 diabetes among more than 1600 patients with schizophrenia who were treated with first- and second-generation antipsychotics.
